Results 191 to 200 of about 146,599 (341)

Herbal medicine at a crossroads. [PDF]

Environmental Health Perspectives, 1996
openaire   +3 more sources

Eco-Friendly Synthesized Carbon Dots from Chinese Herbal Medicine: A Review. [PDF]

Int J Nanomedicine
Zhao Y, Li Y, Li D, Yuan H, Shen C.
europepmc   +1 more source

Effect of Mild to Moderate Hepatic Impairment on Valemetostat Pharmacokinetics: An Open‐Label, Phase I Study

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Valemetostat tosylate (valemetostat) is a dual inhibitor of enhancer of zeste homolog (EZH) 2 and EZH1, approved in Japan for the treatment of relapsed/refractory peripheral T‐cell lymphoma and adult T‐cell leukemia/lymphoma. This Phase I, open‐label study evaluated the pharmacokinetics and safety of a single 50‐mg oral dose of valemetostat in
Masaya Tachibana, Thuy Vu Craveiro, Thomas C. Marbury, Samuel Oberstein, George J. Atiee, Ben Tao, Takako Shimizu, Yvonne Lau, Malaz A. Abutarif   +8 more
wiley   +1 more source

Herbal Medicine-Associated Lead Intoxication.

, 1997
Setsuo Hasegawa, Kazutaka Nakayama, Katsuhiko Iwakiri, Emi An, Seiji Gomi, Kazuo Dan, Masao Katsumata, Masayasu Minami, Ichiji Wakabayashi   +8 more
openalex   +2 more sources

International monitoring of adverse health effects associated with herbal medicines [PDF]

, 2000
Mohamed Farah, Ralph Edwards, Marie Lindquist, Christine Léon, Debbie Shaw   +4 more
openalex   +1 more source

Herbal Medicine Use Among Transplant Recipients in Saudi Arabia: Prevalence and Risk Awareness. [PDF]

Ann Transplant
Almalki BA, Alotaibi FM, Aldholmi M, Alqarni YS, Kurdi SM, Alsultan MM, Alzlaiq WA, Alotaibi MM, Alashi NM, Alzahrani FS, Alotaibi NE, Albekery MA, Albilal SA, Kahtani KM, Gafar MA, Al-Mowaina SM, Alalawi AK, Alshehab AA, Aljasem AJ, Albekairy AM.   +19 more
europepmc   +1 more source

Discovering Severe Adverse Reactions From Pharmacokinetic Drug–Drug Interactions Through Literature Analysis and Electronic Health Record Verification

Clinical Pharmacology &Therapeutics, Volume 117, Issue 4, Page 1078-1087, April 2025.
While drug–drug interactions (DDIs) and their pharmacokinetic (PK) mechanisms are well‐studied prior to drug approval, severe adverse drug reactions (SADRs) caused by DDIs often remain underrecognized due to limitations in pre‐marketing clinical trials.
Eugene Jeong, Yu Su, Lang Li, You Chen
wiley   +1 more source

Monoamine Oxidase Inhibitory Naphthoquinone and/or Naphthalene Dimers from Lemuni Hitam (Diospyros sp.), a Malaysian Herbal Medicine.

, 1999
Emi Okuyama, Masayuki Homma, Yoko Satoh, Haruhiro Fujimoto, Masami Ishibashi, Mikio Yamazaki, Motoyoshi Satake, Azizi Bin Aiyub Ghazali   +7 more
openalex   +2 more sources

Exploring the dielectric properties of herbal medicine and modern pharmaceuticals: an integrative review. [PDF]

Front Pharmacol
Khatri V, Dey PK.
europepmc   +1 more source

In vitro metabolism study of ADB‐P‐5Br‐INACA and ADB‐4en‐P‐5Br‐INACA using human hepatocytes, liver microsomes, and in‐house synthesized references

Drug Testing and Analysis, Volume 17, Issue 5, Page 701-712, May 2025.
Analyzing hepatocytes and liver microsomes samples along with synthesized references. Complete structure elucidation of major metabolites was possible, and biomarkers for both ADB‐P‐5Br‐INACA and ADB‐4en‐P‐5Br‐INACA were suggested. Abstract Synthetic cannabinoids (SCs) remain a major public health concern, as they continuously are linked to severe ...
Tobias Rautio, Robin Obrist, Lucas Krebs, Therése Klingstedt, Johan Dahlén, Xiongyu Wu, Henrik Gréen   +6 more
wiley   +1 more source